MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, today announced its financial results for the three and six months ended June 30, 2019, including strong growth in revenue, EBITDA, net income and earnings per share. KEY Q2 2019 HIGHLIGHTS(2) Revenue was $31.5 […]
The post MediPharm Labs Reports Strong, Profitable Second Quarter Results appeared first on Technical420.
You may also like
-
Looking For Marijuana Stocks To Buy? 2 Analysts Expect To Have Upside In 2021
-
Trulieve Cannabis Corp. (TCNNF) Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
-
Harborside Inc. (HBORF) Announces Upcoming Conference Participation
-
Cresco Labs Inc. (CRLBF) Expands Branded Edibles Portfolio With Launch of Wonder Wellness Gummies
-
Aphria Inc. (APHA) Announces Third Quarter Fiscal Year 2021 Results